232 related articles for article (PubMed ID: 32027758)
21. Improving the passive permeability of macrocyclic peptides: Balancing permeability with other physicochemical properties.
Thansandote P; Harris RM; Dexter HL; Simpson GL; Pal S; Upton RJ; Valko K
Bioorg Med Chem; 2015 Jan; 23(2):322-7. PubMed ID: 25533323
[TBL] [Abstract][Full Text] [Related]
22. Prediction of Chameleonic Efficiency.
David L; Wenlock M; Barton P; Ritzén A
ChemMedChem; 2021 Sep; 16(17):2669-2685. PubMed ID: 34240561
[TBL] [Abstract][Full Text] [Related]
23. Solubility prediction in the bRo5 chemical space: where are we right now?
Ermondi G; Poongavanam V; Vallaro M; Kihlberg J; Caron G
ADMET DMPK; 2020; 8(3):207-214. PubMed ID: 35300306
[TBL] [Abstract][Full Text] [Related]
24. Effect of Flexibility, Lipophilicity, and the Location of Polar Residues on the Passive Membrane Permeability of a Series of Cyclic Decapeptides.
Wang S; König G; Roth HJ; Fouché M; Rodde S; Riniker S
J Med Chem; 2021 Sep; 64(17):12761-12773. PubMed ID: 34406766
[TBL] [Abstract][Full Text] [Related]
25. Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural products.
Ahlbach CL; Lexa KW; Bockus AT; Chen V; Crews P; Jacobson MP; Lokey RS
Future Med Chem; 2015; 7(16):2121-30. PubMed ID: 26067057
[TBL] [Abstract][Full Text] [Related]
26. Interplay among Conformation, Intramolecular Hydrogen Bonds, and Chameleonicity in the Membrane Permeability and Cyclophilin A Binding of Macrocyclic Peptide Cyclosporin O Derivatives.
Lee D; Lee S; Choi J; Song YK; Kim MJ; Shin DS; Bae MA; Kim YC; Park CJ; Lee KR; Choi JH; Seo J
J Med Chem; 2021 Jun; 64(12):8272-8286. PubMed ID: 34096287
[TBL] [Abstract][Full Text] [Related]
27. Conformation and Permeability: Cyclic Hexapeptide Diastereomers.
Ono S; Naylor MR; Townsend CE; Okumura C; Okada O; Lokey RS
J Chem Inf Model; 2019 Jun; 59(6):2952-2963. PubMed ID: 31042375
[TBL] [Abstract][Full Text] [Related]
28. Rationalization of the Membrane Permeability Differences in a Series of Analogue Cyclic Decapeptides.
Witek J; Wang S; Schroeder B; Lingwood R; Dounas A; Roth HJ; Fouché M; Blatter M; Lemke O; Keller B; Riniker S
J Chem Inf Model; 2019 Jan; 59(1):294-308. PubMed ID: 30457855
[TBL] [Abstract][Full Text] [Related]
29. Highly Conformationally Restricted Cyclopropane Tethers with Three-Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides.
Matsui K; Kido Y; Watari R; Kashima Y; Yoshida Y; Shuto S
Chemistry; 2017 Mar; 23(13):3034-3041. PubMed ID: 27878880
[TBL] [Abstract][Full Text] [Related]
30. Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space.
Caron G; Kihlberg J; Goetz G; Ratkova E; Poongavanam V; Ermondi G
ACS Med Chem Lett; 2021 Jan; 12(1):13-23. PubMed ID: 33488959
[TBL] [Abstract][Full Text] [Related]
31. Design Principles for Balancing Lipophilicity and Permeability in beyond Rule of 5 Space.
Möbitz H
ChemMedChem; 2024 Mar; 19(5):e202300395. PubMed ID: 37986275
[TBL] [Abstract][Full Text] [Related]
32. Cyclic Peptide Design Guided by Residual Dipolar Couplings, J-Couplings, and Intramolecular Hydrogen Bond Analysis.
Farley KA; Che Y; Navarro-Vázquez A; Limberakis C; Anderson D; Yan J; Shapiro M; Shanmugasundaram V; Gil RR
J Org Chem; 2019 Apr; 84(8):4803-4813. PubMed ID: 30605335
[TBL] [Abstract][Full Text] [Related]
33. The effect of conformation of the acyloxyalkoxy-based cyclic prodrugs of opioid peptides on their membrane permeability.
Gudmundsson OS; Vander Velde DG; Jois SD; Bak A; Siahaan TJ; Borchardt RT
J Pept Res; 1999 Apr; 53(4):403-13. PubMed ID: 10406218
[TBL] [Abstract][Full Text] [Related]
34. Property-Driven Development of Passively Permeable Macrocyclic Scaffolds Using Heterocycles.
Saunders GJ; Yudin AK
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202206866. PubMed ID: 35687524
[TBL] [Abstract][Full Text] [Related]
35. Structural Flexibility of Cyclosporine A Is Mediated by Amide
Gray ALH; Steren CA; Haynes IW; Bermejo GA; Favretto F; Zweckstetter M; Do TD
J Phys Chem B; 2021 Feb; 125(5):1378-1391. PubMed ID: 33523658
[TBL] [Abstract][Full Text] [Related]
36. Toward the elucidation of the mechanism for passive membrane permeability of cyclic peptides.
Riniker S
Future Med Chem; 2019 Apr; 11(7):637-639. PubMed ID: 30920310
[No Abstract] [Full Text] [Related]
37. Form and function in cyclic peptide natural products: a pharmacokinetic perspective.
Bockus AT; McEwen CM; Lokey RS
Curr Top Med Chem; 2013; 13(7):821-36. PubMed ID: 23578026
[TBL] [Abstract][Full Text] [Related]
38. Going Out on a Limb: Delineating The Effects of β-Branching, N-Methylation, and Side Chain Size on the Passive Permeability, Solubility, and Flexibility of Sanguinamide A Analogues.
Bockus AT; Schwochert JA; Pye CR; Townsend CE; Sok V; Bednarek MA; Lokey RS
J Med Chem; 2015 Sep; 58(18):7409-18. PubMed ID: 26308180
[TBL] [Abstract][Full Text] [Related]
39. Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility.
Naylor MR; Ly AM; Handford MJ; Ramos DP; Pye CR; Furukawa A; Klein VG; Noland RP; Edmondson Q; Turmon AC; Hewitt WM; Schwochert J; Townsend CE; Kelly CN; Blanco MJ; Lokey RS
J Med Chem; 2018 Dec; 61(24):11169-11182. PubMed ID: 30395703
[TBL] [Abstract][Full Text] [Related]
40. A New Amino Acid for Improving Permeability and Solubility in Macrocyclic Peptides through Side Chain-to-Backbone Hydrogen Bonding.
Taechalertpaisarn J; Ono S; Okada O; Johnstone TC; Lokey RS
J Med Chem; 2022 Mar; 65(6):5072-5084. PubMed ID: 35275623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
